Bentley InnoMed

Bentley Global specializes in high-end medical technology aimed at improving patient care and health outcomes. The company focuses on developing advanced stent graft systems for large diameter vessels, particularly targeting peripheral and venous stenting. These stent systems are designed to respect the natural venous anatomy and offer an optimal balance between radial force, flexibility, and deployment behavior. Bentley Global's products include the BeYond Venous Self Expanding Stent System, BeGraft Coronary Stent System, BeGraft Aortic Stent Graft System, and BeGraft Peripheral PLUS Stent Graft System. These systems are characterized by their use of a cobalt chrome stent platform covered with a micro porous ePTFE membrane, providing high radial force and flexibility. The company's primary clients are healthcare providers and medical institutions that require advanced stent graft solutions for treating widespread diseases like thrombosis. Bentley Global operates in the medical technology market and follows a business model that involves the development, manufacturing, and sale of its specialized stent graft systems. The company generates revenue through the direct sale of its products to medical institutions and healthcare providers. However, it is important to note that many of Bentley Global's products are not available in the US market.

Keywords: medical technology, stent graft systems, venous stenting, radial force, flexibility, cobalt chrome, ePTFE membrane, thrombosis, healthcare providers, patient care.